# Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis

> **NCT02475447** · PHASE2 · COMPLETED · sponsor: **Tioga Pharmaceuticals** · enrollment: 249 (actual)

## Conditions studied

- Pruritus
- Atopic Dermatitis

## Interventions

- **DRUG:** Asimadoline
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02475447
- **Lead sponsor:** Tioga Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07
- **Primary completion:** 2017-06
- **Final completion:** 2017-06
- **Target enrollment:** 249 (ACTUAL)
- **Last updated:** 2017-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02475447

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02475447, "Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02475447. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*